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An enzyme-linked immunosorbent assay (ELISA) was evaluated for the detection of measles virus-specific immunoglobulin M (IgM) (MIgM). The MIgM ELISA. U-shaped polyvinyl chloride microtiter plates (Linbro/Titertek; Flow Laboratories, Inc., McLean, Va.) were coated with 0.1 ml of caprine anti-human IL antibody (Tago, Inc., Burlingame, Calif.) (6) . By testing serial dilutions, a concentration of 1:5,000 in carbonate buffer (pH 9.6) was found to be optimal and was used in all subsequent experiments (14) . Plates were stored at 4°C for a minimum of 24 h before use. Washing after removal of the coating fluid was repeated four times with PBS-T; all subsequent washings were done in this manner. The plate was then "postcoated" with 0.1 ml of 1% bovine serum albumin (Sigma Chemical Co.) in PBS-T (6) containing 0.2% sodium azide (Sigma Chemical Co.). This and all subsequent incubations were performed at 37°C in a moist chamber for 1 h. Incubation of the human sera at 4°C overnight (13) essentially the same results as 1 h of incubation latter was chosen for all subsequent experinf assay could be performed in a single day.
Serial dilutions of all reagents were teste combinations to achieve the clearest separati seropositive and seronegative. All reagents w 0.1-ml volumes. Decanting and washing wei between each of the successive steps. A 1:1( each serum sample was prepared in 1% heat-ina calf serum-10% globulin-poor normal goat sen The preparation of the latter by precipitation w described elsewhere (9) . A 1:150 dilution of M control (5) in PBS-T was then added to each o or "control" wells, respectively. Subsequent dilution of guinea pig serum collected aftei booster and diluted in PBS-T was added. Goz pig serum conjugated (14) to alkaline phosphata PBS-T) was then added. Finally, the substra p-nitrophenyl phosphate (Sigma Chemical Co.) anolamine (14) b Seronegative for MIgG (see text). The seronegative range was determined with 47 sera drawn from children before the administration of measles-mumpsrubella vaccine (mean, 0.008; standard deviation, 0.016) as previously described (1, 8) .
The 20 sera containing RF were found to have MIgG (range of DOD values, 0.335 to 1.325); in the MIgM ELISA, all had DOD values below 0.075 (range, 0.034 to 0.057). The five pairs of sera obtained from patients with rubella all were in the MIgM-seronegative range.
DISCUSSION
The assay described is sensitive and specific and ideally suited for serological confirmation of recent measles infection. MIgM was detectable shortly after the onset of clinical (3, 11, 12) ; additional manipulations have been necessary to remove RF. RF is commonly produced following viral infections (8, 11) , including measles (11, 12) . Thus, it is essential that this source of false-positive reactions be eliminated. By use of the antibody class capture assay, nonspecificity caused by RF was either markedly reduced (12) or not found (7). In our MIgM assay, none of 20 RF-positive sera were found to give false-positive results. The specificity of the system was further confirmed by finding that sera containing MIgM lost activity after treatment with DTT. Sera from patients with rubella, a disease sometimes confused with measles, lacked MIgM.
A single serum specimen submitted early in the course of an illness may provide an etiologic diagnosis in cases of suspected measles or in an uncertain febrile exanthema. At present, it is usually necessary to demonstrate a significant rise in total IgG to confirm a clinical diagnosis. For this reason, a second serum specimen must be obtained; if this is not available, the IgG assay of a single serum specimen may be difficult to interpret. Many of our patients already had higher levels of IgG in their initial serum specimens than in many convalescent-phase specimens. If a second serum VOL. 24, 1986 on September 29, 2017 by guest http://jcm.asm.org/ specimen is available, reporting of results must await the testing of that specimen. In several serum samples, moreover, a rise in IgG titer could not be shown. In contrast to this, MIgM was detected in 21 of 25 initial serum samples (84%) drawn up to 10 days after onset. In four other individuals who were initially seronegative, a subsequent serum sample was necessary; all of these were found to be positive for MIgM. In cases in which the initial serum sample is negative, therefore, a second serum sample drawn 1 to 3 weeks after the onset of illness should be tested. If this is also negative for MIgM, the diagnosis of measles is unlikely.
The MIgM ELISA has the advantage of not requiring the separation of IgM from the other serum antibodies or techniques to remove IgM or IgG. It can also be completed in one working day and requires only a small volume, 0.005 ml, of serum.
